Pharmacy Times

AUGUST 1, 2025

PBMs are more powerful and influential than ever as they become extensions of major health insurers, acquire independent pharmacies, and create new business lines to funnel prescriptions through. Accessed July 23, 2025. January 14, 2025. Accessed July 23, 2025. Accessed July 23, 2025. Here’s How. April 9, 2024.

Specialty Pharmacies

Pharmacy Times

AUGUST 11, 2025

Most MTM platforms use health plan adjudication data, allowing pharmacists to see any medication billed through the patient’s insurance, even if it was not filled at their pharmacy. Accessed July 7, 2025. Accessed July 7, 2025. April 14, 2025. Accessed July 7, 2025. Accessed July 7, 2025. December 15, 2024.

Hospitals

Pharmacy Times

JULY 12, 2025

At McKesson ideaShare 2025, pharmacy leaders spotlighted the growing role of pharmacists in expanding clinical services, including telehealth, contraception prescribing, naloxone access, and point-of-care testing (POCT). Presented at: McKesson ideaShare 2025. Nashville, TN; July 11, 2025. Accessed July 11, 2025.

Independent Pharmacies

Pharmacy Times

JULY 22, 2025

These third-party administrators act as intermediaries between drug manufacturers, pharmacies, and insurance companies. These deserts reduce access to critical health care services, such as vaccinations, health screenings, and point-of-care testing. Additionally, the role of pharmacy benefit managers (PBMs) cannot be overlooked.

Mail-Order Pharmacies

Drug Topics

JULY 5, 2025

Kevin Cleveland, PharmD, professor at Idaho State University, explores the potential impacts of changes to the Advisory Committee on Immunization Practices (ACIP), highlighting concerns about shifting medical guidance and vaccine recommendations. Cleveland: So I'll start as a provider. So I think it's going to limit access.

Patient Care

Pharmacy Times

JULY 21, 2025

The most common concerns include the following 1,3-5 : • Cost and insurance barriers: Affordability remains a major barrier, as patients have difficulty accessing CGMs due to high out-of-pocket costs or limited insurance coverage. Accessed June 17, 2025. Updated February 2025. Accessed June 17, 2025. Clin Diabetes.

Compounding Pharmacies

Pharmacy Times

JULY 25, 2025

Additional considerations for selection between oral cephalosporin agents include differences in bioavailability and absorption, specific site of infection and the ability of drug to concentrate at that site, local resistance patterns, insurance coverage, available formulations, and cost to the patient. Accessed March 2, 2025.

HIV Treatment and Prevention Agents

Drug Topics

JUNE 23, 2025

Successful RCM implementation can help pharmacies recover significant funds, with Outcomes reporting nearly $3 million recovered for clients in 2024 and 2025.

Patient Care

Pharmacy Times

JULY 24, 2025

The FDA’s Prescription Drug User Fee Act date for finerenone is in July 2025. Christopher Ho, PharmD, BCPS, manager of pharmacy telehealth team at Northwell Health, pointed out that many patients with HFpEF are older and lack commercial insurance, making it harder to access branded therapies. March 17, 2025. News release.

HIV Treatment and Prevention Agents

Pharmacy Times

JULY 4, 2025

Patients with inflammatory conditions achieved similar clinical outcomes after switching from the reference adalimumab (Humira; AbbVie) to a biosimilar, according to real-world data presented at the 2025 American Society of Health-System Pharmacists Pharmacy Futures Meeting. Accessed June 26, 2025. June 12, 2025. June 7–11.

Specialty Pharmacies

Drug Topics

JULY 24, 2025

Kennedy Jr signed to adopt the CDC's Advisory Committee on Immunization Practices (ACIP) recommendations to remove mercury-based thimerosal from all influenza vaccines distributed in the United States. Kennedy, Jr, endorses ACIP's decision to eliminate thimerosal from US influenza vaccines, prioritizing public health and safety.

Specialty Pharmacies

Pharmacy Times

JULY 1, 2025

Because] insurance and cost barriers can be difficult for patients, pharmacists can help patients navigate copayment programs and the prior authorization process.” Accessed June 30, 2025. March 21, 2025. Accessed June 30, 2025. Accessed June 30, 2025. Updated February 3, 2025. Accessed June 30, 2025.

HIV Treatment and Prevention Agents

Pharmacy Times

JULY 23, 2025

Pharmacists are pivotal in patient counseling, therapy selection, and navigating insurance challenges, ensuring comprehensive diabetes management. She also noted the insurance considerations, including involvement with formularies and prior authorization, that come into play when making these decisions.

Insurance

Pharmacy Times

JULY 22, 2025

While the European Medicines Agency mandated pre-treatment DPD testing in Europe as early as 2020, and the UK’s National Health Service followed suit the same year, the US only reached a consensus in 2025. Accessed July 21, 2025. Accessed July 21, 2025. Accessed July 21, 2025. European Medicines Agency. link] NHS England.

Compounding Pharmacies

Pharmacy Times

JUNE 16, 2025

3,4 How this pricing model will be implemented and whether pharmaceutical manufacturers will be able to meet the expectations of the 2025 executive order, if upheld, is uncertain. Second, it does not address the core issues of higher prices, such as the use of rebates by insurers. May 12, 2025. Accessed May 13, 2025.

Compounding Pharmacies

Pharmacy Times

JULY 28, 2025

Treatment selection is influenced by insurance, cost, and patient-specific factors due to the lack of direct RCT comparisons. At the American Association of Psychiatric Pharmacists 2025 Annual Meeting in Salt Lake City, Utah, Kayla Johnson, PharmD, BCPS, BCPP, presented on the management of TD with VMAT2 inhibitors in greater detail.

Compounding Pharmacies

Pharmacy Times

JUNE 23, 2025

Goldman and Isaacs emphasize the importance of identifying at-risk patients through various health care touchpoints, including doctor's offices and pharmacies, and advocate for routine glucagon prescription and insurance coverage. But I also think everyone should have a ready-to-use cover on their insurance.

Compounding Pharmacies

Pharmacy Times

JUNE 17, 2025

That means that pharmacists in the twilight of their career have, at some point, filled a prescription, engaged in drug utilization review, filed insurance claims, and counseled per the Omnibus Budget Reconciliation Act of 1990 regulations for many of the products now found in front of the counter. Accessed May 5, 2025. November 2022.

Compounding Pharmacies

Pharmaceutical Commerce

JUNE 17, 2025

This is especially critical for temperature-sensitive biologics and vaccines, where maintaining proper storage conditions ensures product viability and regulatory compliance. Jeff Webber Key Takeaways Real-world data enhances medication safety and supply chain efficiency.

Health and Personal Care Stores

Pharmaceutical Technology

JULY 4, 2025

How will RFK Jr’s American dream for vaccines play out? Robert Barrie July 4, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Only 4% of global drugs sales in 2030 will have patent protection. In May 2025, the US president signed an executive order that overhauled pharmaceutical pricing in the country.

Chemotherapy

Pharmacy Times

JULY 3, 2025

Getting this passed would mean broadening coverage within CMS, and then, hopefully, private insurers would follow suit. CMS leads the way when it comes to new therapies and approval, so hopefully, this means broadening access to both private and government-based insurers.

Compounding Pharmacies

Pharmacy Times

JULY 1, 2025

You also look at sometimes the unfortunate situation of the patient's insurance, for example, no longer covering the medication, whether it's an insurance formulary change or, for example, a patient switches insurances due to a job change. We on our own help to navigate patients through that process as well.

Specialty Pharmacies

Pharmaceutical Technology

JUNE 27, 2025

June 27, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The alliance between the two entities will increase the production of new cancer therapies such as CAR T-cell treatment. Give your business an edge with our leading industry insights. Login Registration is disabled.

Communication

Pharmaceutical Technology

JUNE 27, 2025

June 27, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Label updates have been approved for BMS’ CAR T cell therapies, Breyanzi and Abecma, to treat multiple myeloma. Give your business an edge with our leading industry insights. Thank you for subscribing View all newsletters from across the GlobalData Media network.

Labelling

Pharmaceutical Technology

JUNE 16, 2025

June 16, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Ethris’ platform technologies have shown favourable results in Phase I trials for ETH47. mRNA vaccine coverage on Pharmaceutical Technology (or Clinical Trials Arena) is supported by Trilink. Credit: Cryptographer/Shutterstock. “By

Vaccines

Pharmacy Times

JULY 24, 2025

Someone ended up donating a car, and they used the money to buy tires and insurance. The patient was moving away and did not have a car. Loy-Helm jumped into action, mobilizing the staff and patients to raise money to buy her a car. Because the pharmacy is in a rural area, Loy-Helm explained, patients have her phone number.

Independent Pharmacies

Pharmaceutical Technology

AUGUST 8, 2025

Using real-world data to support vaccine outreach and education Buy Reports Newsletters PT News EpiPen patent expiry opens new era for innovation The expiration of Viatris’s EpiPen patent in September 2025 will likely result in increased competition and lower costs in the epinephrine delivery space. Login Registration is disabled.

Packaging

Pharmaceutical Technology

JULY 1, 2025

How will RFK Jr’s American dream for vaccines play out? Frankie Fattorini July 1, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The EU Pharma Package’s attempt to balance priorities risks achieving none. Photo by SvetaZi/iStock via Getty Images. Give your business an edge with our leading industry insights.

Packaging

Pharmaceutical Technology

AUGUST 8, 2025

Using real-world data to support vaccine outreach and education Buy Reports Newsletters PT News MAXONA Pharma seeks FDA approval for pain relief MAX-001 MAX-001 provides both rapid onset and extended duration of analgesia. In early 2025, Phase I clinical trial data of the therapy showed it to be well-tolerated among participants.

FDA

Pharmaceutical Technology

JULY 16, 2025

How will RFK Jr’s American dream for vaccines play out? July 16, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Acumen and JCR have conducted feasibility studies assessing their combined technologies. Credit: Gorodenkoff/Shutterstock. Don’t let policy changes catch you off guard. Login Registration is disabled.

Packaging

Pharmaceutical Technology

JUNE 20, 2025

Robert Barrie June 20, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The positive opinion issued by the EMA’s Committee for Medicinal Products for Human Use (CHMP) signals a strong chance that its drug will be approved. A decision is expected in August 2025. Login Registration is disabled.

Communication

Pharmaceutical Technology

JULY 1, 2025

How will RFK Jr’s American dream for vaccines play out? July 1, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Piramal Pharma Solutions Lexington expansion groundbreaking. A ground-breaking ceremony was held on 25 June 2025 to mark the commencement of work on Lexington’s site expansion.

Communication

Pharmaceutical Technology

JULY 18, 2025

How will RFK Jr’s American dream for vaccines play out? Ross Law July 18, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Anaphylaxis is a sudden, severe and occasionally life-threatening allergic reaction that causes a drop in blood pressure and breathing difficulties. Login Registration is disabled.

Packaging

Pharmacy Times

JUNE 22, 2025

They highlighted that only 4% of the 15 million people using insulin have a glucagon prescription, largely due to misconceptions about ease of use, cost, and insurance coverage. My insurance isn't going to cover it, and so people don't even try to prescribe it. Subscribe Now!

Compounding Pharmacies

Pharmaceutical Technology

AUGUST 4, 2025

Using real-world data to support vaccine outreach and education Buy Reports Newsletters PT News Sandoz bolsters in-house biosimilar manufacturing with Evotec acquisition The generics specialist will acquire Just – Evotec Biologics’ biosimilar development and manufacturing plant for $300m. Login Registration is disabled.

Communication

Pharmaceutical Technology

JULY 7, 2025

How will RFK Jr’s American dream for vaccines play out? July 7, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Ekterly is intended for treating acute attacks of hereditary angioedema. In April 2025, KalVista Pharmaceuticals granted Kaken Pharmaceutical the commercialisation rights for sebetralstat in Japan.

FDA

Pharmaceutical Technology

AUGUST 7, 2025

Using real-world data to support vaccine outreach and education Buy Reports Newsletters PT News FDA gives accelerated approval to Jazz Pharma’s diffuse midline glioma therapy Modeyso is expected to be commercially available in late summer 2025. Stay proactive with real-time data and expert analysis.

FDA